Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 06 Mar 2023 for Concert Pharmaceuticals, INC.. Read the official filing
Filing timeline
BuySaleMarc A. Becker
Insider track record
Disclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Marc A. Becker: trading record in brief
Marc A. Becker (finance chief) discloses dealings in Concert Pharmaceuticals, Inc. to SEC (Form 4). Between 16 August 2021 and 6 March 2023, the trades on record add up to 8 filings.
Every open-market trade on record is a sale: 6 sales worth €153k. Other entries cover 1 share grant. So far in 2023, the count stands at no purchases and 3 sales.
On 6 March 2023 came the latest disclosure, a transaction in Concert Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Marc A. Becker
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
56,264 sharesCommon StockSEC:0001209191-23-016162:0
3,762 shares@ US$8.3316.1% of flowCommon StockSEC:0001209191-23-009947:0
8,493 shares@ US$8.3535.9% of flowCommon StockSEC:0001209191-23-005619:0
2,893 shares@ US$7.2511.0% of flowCommon StockSEC:0001209191-23-002550:0
3,762 shares@ US$3.086.7% of flowCommon StockSEC:0001209191-22-010071:0
63,700 sharesCommon StockSEC:0001209191-22-005873:0
2,894 shares@ US$3.205.4% of flowCommon StockSEC:0001209191-22-002398:0
7,304 shares@ US$3.2813.3% of flowCommon StockSEC:0001209191-21-051817:0
8 of 8 declarations
